The Image Biomarker Standardisation Initiative (IBSI) aims to improve reproducibility of radiomics studies by standardising the computational process of extracting image biomarkers (features) from images. We have previously established reference values for 169 commonly used features, created a standard radiomics image processing scheme, and developed reporting guidelines for radiomic studies. However, several aspects are not standardised. Here we present a preliminary version of a reference manual on the use of convolutional image filters in radiomics. Filters, such as wavelets or Laplacian of Gaussian filters, play an important part in emphasising specific image characteristics such as edges and blobs. Features derived from filter response maps have been found to be poorly reproducible. This reference manual forms the basis of ongoing work on standardising convolutional filters in radiomics, and will be updated as this work progresses.
The image biomarker standardisation initiative (IBSI) is an independent international collaboration which works towards standardising the extraction of image biomarkers from acquired imaging for the purpose of high-throughput quantitative image analysis (radiomics). Lack of reproducibility and validation of high-throughput quantitative image analysis studies is considered to be a major challenge for the field. Part of this challenge lies in the scantiness of consensus-based guidelines and definitions for the process of translating acquired imaging into high-throughput image biomarkers. The IBSI therefore seeks to provide image biomarker nomenclature and definitions, benchmark data sets, and benchmark values to verify image processing and image biomarker calculations, as well as reporting guidelines, for high-throughput image analysis.
Image features need to be robust against differences in positioning, acquisition and segmentation to ensure reproducibility. Radiomic models that only include robust features can be used to analyse new images, whereas models with non-robust features may fail to predict the outcome of interest accurately. Test-retest imaging is recommended to assess robustness, but may not be available for the phenotype of interest. We therefore investigated 18 methods to determine feature robustness based on image perturbations. Test-retest and perturbation robustness were compared for 4032 features that were computed from the gross tumour volume in two cohorts with computed tomography imaging: I) 31 non-small-cell lung cancer (NSCLC) patients; II): 19 head-and-neck squamous cell carcinoma (HNSCC) patients. Robustness was measured using the intraclass correlation coefficient (1,1) (ICC). Features with ICC$\geq0.90$ were considered robust. The NSCLC cohort contained more robust features for test-retest imaging than the HNSCC cohort ($73.5\%$ vs. $34.0\%$). A perturbation chain consisting of noise addition, affine translation, volume growth/shrinkage and supervoxel-based contour randomisation identified the fewest false positive robust features (NSCLC: $3.3\%$; HNSCC: $10.0\%$). Thus, this perturbation chain may be used to assess feature robustness.